CD8A and neoplasm: The up-regulated ID2 induces the expression of interleukin-12 (IL-12) receptors on the surface of CD8+ T cells, thereby modulating IL-12 signaling, promoting the infiltration of CD8+ T cells into tumor tissues, enhancing IFN-γ secretion, and ultimately strengthening T cell-mediated antitumor immune responses.